REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients
← catalyst calendarNCT04687358 · readout ≤ 955 d
Sponsored by Kiniksa Pharmaceuticals International, plc (industry) · KNSA — their whole pipeline →. With Kiniksa Pharmaceuticals (UK), Ltd..
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
500estimated
Sites
29
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2021-03-16 | actual | When the study began enrolling |
| Primary completion | Mar 2029 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Mar 2029 | estimated | The whole study's end, after follow-up |
| First posted | 2020-12-29 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-02-17 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Recurrent Pericarditis
Primary outcome
what the primary-completion date above is the date OFPatients using 1 or more RP treatments
measured 5 years
Permalink · KNSA's whole pipeline · Catalyst calendar · Every registered study · What changed